Prognostic significance of variants in the CTNNB1 gene and the B-catenin pathway in recurrent high-intermediate risk endometrial cancer
Details
Age
Adult
Type of Study
Other
Locations
University of Colorado Hospital
Principal Investigator
Jennifer Haag
Study ID
Protocol Number: 19-1199
More information available at ClinicalTrials.gov: NCT00000000
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers